Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3052)
All Articles published online
|
Jun 15, 2001 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | You J, Zhuang L, Tang BZ, Yang WB, Ding SY, Li W, Wu RX, Zhang HL, Zhang YM, Yan SM, Zhang L. Randomized controlled clinical trial on the treatment of Thymosin-a1 vs interferon-α in patients with hepatitis B. World J Gastroenterol 2001; 7(3): 411-414 [PMID: 11819801 DOI: 10.3748/wjg.v7.i3.411] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/411.htm |
| Number | Citing Articles |
| 1 |
Yui-Jie Bai, Jin-Rong Zhao, Guan-Ting Lv, Wen-Hong Zhang, Yan Wang, Xiao-Jun Yan. Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization. World Journal of Gastroenterology 2003; 9(10): 2344-2347 doi: 10.3748/wjg.v9.i10.2344
|
| 2 |
Xiaoning Wu, Jidong Jia, Hong You. Thymosin alpha-1 treatment in chronic hepatitis B. Expert Opinion on Biological Therapy 2015; 15(sup1): 129 doi: 10.1517/14712598.2015.1007948
|
| 3 |
S. Iino, J. Toyota, H. Kumada, K. Kiyosawa, S. Kakumu, M. Sata, H. Suzuki, E. B. Martins. The efficacy and safety of thymosin alpha‐1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. Journal of Viral Hepatitis 2005; 12(3): 300 doi: 10.1111/j.1365-2893.2005.00633.x
|
| 4 |
A. Ciancio, M. Rizzetto. Thymalfasin in the treatment of hepatitis B and C. Annals of the New York Academy of Sciences 2010; 1194(1): 141 doi: 10.1111/j.1749-6632.2010.05487.x
|
| 5 |
YUN‐FAN LIAW. Thymalfasin (thymosin‐alpha 1) therapy in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2004; 19(S6) doi: 10.1111/j.1440-1746.2004.03633.x
|
| 6 |
Timothy M. Block, Siddhartha Rawat, Carol L. Brosgart. Chronic hepatitis B: A wave of new therapies on the horizon. Antiviral Research 2015; 121: 69 doi: 10.1016/j.antiviral.2015.06.014
|
| 7 |
Hong-Lei Han, Zhen-Wei Lang. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment. World Journal of Gastroenterology 2003; 9(1): 117-121 doi: 10.3748/wjg.v9.i1.117
|
| 8 |
Stephanos J Hadziyannis, George V Papatheodoridis. Emerging treatments in chronic hepatitis B. Expert Opinion on Emerging Drugs 2004; 9(2): 207 doi: 10.1517/14728214.9.2.207
|
| 9 |
Jing You, Lin Zhuang, Hong-Ying Cheng, Shou-Ming Yan, Lan Yu, Jun-Hua Huang, Bao-Zhang Tang, Meng-Ling Huang, Yong-Liang Ma, Virasakdi Chongsuvivatwong, Hutcha Sriplung, Alan Geater, Yan-Wei Qiao, Rong-Xue Wu. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: A randomized controlled study. World Journal of Gastroenterology 2006; 12(41): 6715-6721 doi: 10.3748/wjg.v12.i41.6715
|
| 10 |
Bo Hyun Kim, Youn-Jae Lee, Won Kim, Jung-Hwan Yoon, Eun Uk Jung, Sung Jae Park, Yoon Jun Kim, Hyo-Suk Lee. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study. Scandinavian Journal of Gastroenterology 2012; 47(8-9): 1048 doi: 10.3109/00365521.2012.694902
|
| 11 |
Pei Fu Chen, Geng Feng Fu, Hong Ying Zhang, Gen Xing Xu, Ya Yi Hou. Liposomal plasmid DNA encoding human thymosin α1 and interferon ω1 potently inhibits liver tumor growth in ICR mice. Journal of Gastroenterology and Hepatology 2006; 21(10): 1538 doi: 10.1111/j.1440-1746.2006.04536.x
|
| 12 |
Zheng-Wen Liu, Qun-Ying Han, Ni Zhang, Wen Kang. Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B. World Journal of Gastroenterology 2004; 10(7): 972-976 doi: 10.3748/wjg.v10.i7.972
|
| 13 |
Rong-Nan Chien, Yun-Fan Liaw. Thymalfasin for the treatment of chronic hepatitis B. Expert Review of Anti-infective Therapy 2004; 2(1): 9 doi: 10.1586/14787210.2.1.9
|
| 14 |
Raymund R. Razonable, James M. McGill. Hepatitis Prevention and Treatment. 2004; : 175 doi: 10.1007/978-3-0348-7903-3_10
|
| 15 |
Guo-Liang Zhang, Ye-Hong Wang, Wei Ni, Hui-Ling Teng, Zhi-Bin Lin. Hepatoprotective role of <italic>ganoderma lucidum</italic> polysaccharide against BCG-induced immune liver injury in mice. World Journal of Gastroenterology 2002; 8(4): 728-733 doi: 10.3748/wjg.v8.i4.728
|
| 16 |
R‐N. Chien, C‐Y. Lin, C‐T. Yeh, Y‐F. Liaw. Hepatitis B virus genotype B is associated with better response to thymosin α1 therapy than genotype C. Journal of Viral Hepatitis 2006; 13(12): 845 doi: 10.1111/j.1365-2893.2006.00761.x
|
| 17 |
Yong-Feng Yang, Wei Zhao, Yan-Dan Zhong, Yi-Jun Yang, Ling Shen, Ning Zhang, Ping Huang. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis. Antiviral Research 2008; 77(2): 136 doi: 10.1016/j.antiviral.2007.10.014
|